The deal is exceptional.
Upfront payment circa $23 mill with a major global distributor.
Margins on manufacture which would be confidential
10% of the market size is $35 mill in sales where OCC will get a manufacturing margin
Validates the Celgro platform which the Remplir nerve repair product sits under an $8 Bill market
Let's not forget the ATI platform market for shoulder repair $3Bill market
Bring on more licensing deals with major players
Lots of money in the bank to do better deals
The deal is exceptional.Upfront payment circa $23 mill with a...
-
- There are more pages in this discussion • 266 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.49M | |||
| Open | High | Low | Value | Volume |
| 36.8¢ | 36.8¢ | 36.5¢ | $19.52K | 53.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 59026 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 16136 | 3 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| OCC (ASX) Chart |